Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Eng Regulatory News (BKY)

Share Price Information for Berkeley Eng (BKY)

Share Price is delayed by 15 minutes
Get Live Data
24.50    -0.80 (-3.16%)
Bid:
24.00
Ask:
25.00
Spread: 1.00 (4.167%)
Market Cap: £109.34m
BKY Live PriceLast checked at - London Stock Exchange

Intraday Berkeley Eng Share Chart

Permitting Update

23 Jul 2021 08:29

RNS Number : 2721G
Berkeley Energia Limited
23 July 2021
 

BERKELEY ENERGIA LIMITED

 

NEWS RELEASE | 23 July 2021

 

Permitting Update

 

Berkeley Energia Limited ("Berkeley" or the "Company") advises that it has taken the first steps to overturn the previously announced unfavorable decision by the Nuclear Safety Council ("NSC") for the grant of the Authorisation for Construction for the uranium concentrate plant as a radioactive facility ("NSC II") at the Company's Salamanca project (see announcement dated 12 July 2021).

 

Berkeley has now submitted an 'Improvement Report' to supplement the Company's initial NSC II Application, along with the corresponding arguments that address all of the issues raised by the NSC, and has requested its reassessment by the NSC. The Improvement Report includes technical arguments that, in the Company's view, will clearly demonstrate that the project is compliant with all requirements for NSC II.

 

This Improvement Report and associated documentation has been submitted to the Ministry of Ecological Transition and Demographic Challenge ("MITECO") following its notification to the Company advising that, in accordance with Spanish administrative law, a hearing process in relation to the NSC's decision has been opened and provides Berkeley with the opportunity to submit relevant documentation to MITECO by 4 August 2021.

 

As previously reported, Berkeley strongly refutes the NSC's assessment and notes that all documentation submitted by the Company in relation to NCS II has been prepared following advice from independent, nationally and internationally recognised advisors and consultants who are experts in their field.

 

It should also be noted that more than 120 previous permits and favourable reports have been granted by the relevant authorities at the local, regional, federal and European Union levels in relation to the Salamanca project, among which nine have been from the NSC.

 

The Company will continue to strongly defend its position in relation to the adverse decision by the NSC and will continue to update the market on any material developments as they occur.

 

 

For further information please contact:

Robert Behets Francisco Bellón

Acting Managing Director Chief Operations Officer

+61 8 9322 6322 +34 91 555 1380

info@berkeleyenergia.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFIFFDDRIVFIL
Date   Source Headline
29th Apr 20267:00 amRNSQuarterly Report March 2026
28th Apr 20267:00 amRNSCeasing to be a Substantial Holder
11th Mar 20267:00 amRNSHalf Year Accounts
11th Mar 20267:00 amRNSHalf Year Accounts
6th Feb 20267:00 amRNSFiling of US$1.25 Billion Statement of Claim
29th Jan 20267:00 amRNSQuarterly Report December 2025
21st Jan 20267:00 amRNSChange in Substantial Holder Notice
24th Dec 20257:00 amRNSIssue of Shares on Exercise of Unlisted Options
19th Dec 20257:00 amRNSReport on Payments to Governments
19th Dec 20257:00 amRNSReport on Payments to Governments
28th Nov 20257:00 amRNSResults of Annual General Meeting
31st Oct 20257:00 amRNSQuarterly Report September 2025
28th Oct 20257:00 amRNSPositive Met Test Work Results at Conchas
23rd Oct 20257:00 amRNSNotice of AGM
3rd Oct 20257:00 amRNSDate of Annual General Meeting
29th Aug 20257:00 amRNSChange in Substantial Holder Notice
27th Aug 20257:03 amRNS2025 Annual Report
31st Jul 20257:00 amRNSQuarterly Report June 2025
30th Apr 20257:00 amRNSQuarterly Report March 2025
23rd Apr 20257:00 amRNSChange in Substantial Holder
25th Mar 20257:00 amRNSASX Price Query
13th Mar 20257:00 amRNSHalf-year Report
31st Jan 20257:00 amRNSQuarterly Report December 2024
29th Jan 20257:00 amRNSShallow, thick zones lithium, rubidium intersected
27th Dec 20247:00 amRNSReport on Payments to Govts
19th Nov 20247:00 amRNSResult of AGM
30th Oct 20247:00 amRNSQuarterly Report September 2024
17th Oct 20247:00 amRNSNotice of Substantial Holder
9th Oct 20247:00 amRNSNotice of AGM
24th Sep 20247:00 amRNSDate of Annual General Meeting
27th Aug 20247:00 amRNS2024 Annual Report
31st Jul 20247:00 amRNSQuarterly Report June 2024
28th May 20247:59 amRNSRequest for Arbitration Submitted against Spain
26th Apr 20247:00 amRNSBoard Changes
26th Apr 20247:00 amRNSQuarterly Report March 2024
10th Apr 20247:32 amRNSCommencement of Arbitration against Spain
13th Mar 20247:05 amRNSHalf-Year Accounts
30th Jan 20247:00 amRNSQuarterly Report December 2023
2nd Jan 20247:00 amRNSExpiry of Unlisted Options
27th Dec 20237:00 amRNSPermitting update
21st Dec 20237:00 amRNSReport on Payments to Govts
21st Nov 20237:00 amRNSResult of AGM
30th Oct 20237:00 amRNSSeptember 2023 Quarterly
11th Oct 20237:00 amRNSNotice of AGM
22nd Sep 20237:00 amRNSDate of Annual General Meeting
30th Aug 20237:00 amRNS2023 Annual Report
26th Jul 20237:57 amRNSIssue of Unlisted Options
24th Jul 20237:00 amRNSQuarterly Report June 2023
19th Jul 20237:00 amRNSResults of Meeting
19th Jun 20237:00 amRNSNotice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.